Skip to main content
. 2017 Aug 15;2017(8):CD007476. doi: 10.1002/14651858.CD007476.pub3

2.30. Analysis.

2.30

Comparison 2 Transfusion‐dependent thalassemia: deferasirox vs deferoxamine, Outcome 30 Time lost from normal activities due to treatment (hours/month): participants treated previously with DFO.